BioStem Technologies, Inc. Stock: price and insider trades · United States
BioStem Technologies, Inc.: what insiders have been doing
This page follows insider dealings at BioStem Technologies, Inc. as filed with SEC (Form 4), a company from the Health Care sector. In the past year (4 November 2025 to 4 November 2026), 13 filings came from 6 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of BioStem Technologies, Inc. for at least a year. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4.
Across the 282 companies tracked on its exchange, the median is 8 filings; at 13 filings, this issuer sits above that mark.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended December 2024 · cache
- 253 shares0Common StockSEC:0001193125-26-445456:0
- 250,000 shares@ US$2.001.01% mcap100.0% of flowCommon StockSEC:0001193125-26-419153:0
- 250,000 shares@ US$2.001.01% mcap100.0% of flowCommon StockSEC:0001193125-26-419152:0
- 8,469 shares0Common StockSEC:0001193125-26-394398:0
- 4,234 shares0Common StockSEC:0001193125-26-394388:0
- 1,694 shares0Common StockSEC:0001193125-26-394390:0
- 7,622 shares0Common StockSEC:0001193125-26-394391:0
- 9,574 shares0Common StockSEC:0001193125-26-394391:1
- 1,694 shares0Common StockSEC:0001193125-26-394397:0
- 16,650 shares0Common StockSEC:0001193125-26-394398:1
- 500 shares0Common StockSEC:0001193125-26-389289:0
- 10,634 shares0Common StockSEC:0002147189-26-000006:0
- 970 shares0Common StockSEC:0002147232-26-000006:0
13 of 13 declarations
About BioStem Technologies, Inc.
BioStem Technologies, Inc. is a company focused on developing cell therapy and regenerative medicine solutions. It is listed on NASDAQ under the ticker XNAS.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
